This breakthrough study shows the antiviral drug obeldesivir administered once daily orally was effective against a lethal challenge of Ebola in non human primates.
This is an NIH funded study, the likes of which are being cut by the current administration.
https://www.science.org/doi/10.1126/sciadv.adw0659